摘要
人蛋白酶活化受体1(PAR-1)是蛋白酶活化受体家族的成员之一.它活化方式特殊,生物学功能广泛.已经证实PAR-1在黑色素瘤、乳腺癌、胃癌、鼻咽癌、前列腺癌癌旁间质、肝癌、结肠癌等组织中表达上调,在肿瘤细胞的增殖和转移过程中发挥重要作用,可作为患者临床病理分期及预后的标志物.
Protease-activated receptor-1 (PAR-l) is a member of protease-activated receptor family. With special activation manner and various functions, PAR-1 has been verified to be up-regulated in melanoma, breast cancer, gastric cancer, nasopharyngeal carcinoma, adjacent stroma of prostate cancer, lung cancer, and colorectal cancer. It plays important roles in tumor proliferation and metastasis, and is regarded as a promising biomarker for clinical pathological staging and prognosis in various malignancies.
出处
《生命科学研究》
CAS
CSCD
北大核心
2012年第3期277-282,共6页
Life Science Research
基金
国家973项目资助(2010CB833605)
教育部新世纪优秀人才支持计划资助项目(NCET-10-0790)
中南大学杰出青年培育资助项目(2010QYZD006)
中南大学贵重仪器设备开放共享基金资助项目(CSUZC2012010
CSUZC2012011)
国家自然科学基金资助项目(30801322
81172206)
湖南省自然科学基金资助项目(10JJ4025)